To date, only a very limited number of studies have focused on the association between PALB2 mutations and hereditary predisposition to breast cancer in China, and ethnic Han Chinese patients were enrolled in most of these studies, with no study addressing multiple ethnic groups in China. This evidence concerns the gene PALB2 and breast carcinoma.